In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics
Authors:
- Jose V. CarrataláJose V. Carratalá
- Eric BrouilletteEric Brouillette
- Naroa SernaNaroa Serna
- Alejandro Sánchez-ChardiAlejandro Sánchez-Chardi
- Julieta M. SánchezJulieta M. Sánchez
- Antonio VillaverdeAntonio Villaverde
- Anna ArísAnna Arís
- Elena Garcia-FruitósElena Garcia-Fruitós
- Neus Ferrer-MirallesNeus Ferrer-Miralles
- François MalouinFrançois Malouin
Open Access
- 17 December 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (12) , 1217
Abstract
Oligomerization of antimicrobial peptides into nanosized supramolecular complexes produced in biological systems (inclusion bodies and self-assembling nanoparticles) seems an appealing alternative to conventional antibiotics. In this work, the antimicrobial peptide, GWH1, was N-terminally fused to two different scaffold proteins, namely, GFP and IFN-γ for its bacterial production in the form of such recombinant protein complexes. Protein self-assembling as regular soluble protein nanoparticles was achieved in the case of GWH1-GFP, while oligomerization into bacterial inclusion bodies was reached in both constructions. Among all these types of therapeutic proteins, protein nanoparticles of GWH1-GFP showed the highest bactericidal effect in an in vitro assay against Escherichia coli, whereas non-oligomerized GWH1-GFP and GWH1-IFN-γ only displayed a moderate bactericidal activity. These results indicate that the biological activity of GWH1 is specifically enhanced in the form of regular multi-display configurations. Those in vitro observations were fully validated against a bacterial infection using a mouse mastitis model, in which the GWH1-GFP soluble nanoparticles were able to effectively reduce bacterial loads.Keywords
Funding Information
- Ministry of Economy and Competitiveness, Spain (RTA2015-00064-C02)
- Natural Sciences and Engineering Research Council of Canada (NSERC 2015-05916)
- Agency for Management of University and Research Grants, Spain (2017 SGR-229)
This publication has 62 references indexed in Scilit:
- Antimicrobial Peptides for Therapeutic Applications: A ReviewMolecules, 2012
- Inclusion bodies: a new conceptMicrobial Cell Factories, 2010
- Antimicrobial peptides: linking partition, activity and high membrane-bound concentrationsNature Reviews Microbiology, 2009
- Engineering inclusion bodies for non denaturing extraction of functional proteinsMicrobial Cell Factories, 2008
- Coutilization of glucose and glycerol enhances the production of aromatic compounds in an Escherichia coli strain lacking the phosphoenolpyruvate: carbohydrate phosphotransferase systemMicrobial Cell Factories, 2008
- Peptide Mimetics of Gamma Interferon Possess Antiviral Properties against Vaccinia Virus and Other Viruses in the Presence of Poxvirus B8R ProteinJournal of Virology, 2005
- The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouseMicrobes and Infection, 2005
- Large-scale manufacture of peptide therapeutics by chemical synthesisNature Reviews Drug Discovery, 2003
- High-Level Expression of Antimicrobial Peptide Mediated by a Fusion Partner Reinforcing Formation of Inclusion BodiesBiochemical and Biophysical Research Communications, 2000
- Controlling acute Escherichia coli mastitis during the periparturient period with recombinant bovine interferon gammaVeterinary Microbiology, 1991